Breast cancer-specific survival association of tumor-proximal adipocyte size validated in ABCTB (n=2,500) after 12-cancer screening

Authors: M. E. Lien, N. H. Halberg.

• Rapid-Fire Presentation, ENDO 2026, Annual Meeting of the Endocrine Society, Chicago, IL, USA, June 13-16, 2026.
• Selected by the Annual Meeting Steering Committee for a Rapid-Fire presentation.
• Presented results from large-scale spatial adipocyte phenotyping across 21,968 digital slides and more than 75 million adipocytes measured across 12 cancer types.
• Demonstrated that tumor-proximal adipocyte size is a breast cancer-specific prognostic marker, with the strongest performance in postmenopausal patients and postmenopausal patients with obesity, and validated the findings in the Australian Breast Cancer Tissue Bank.